IP Library Granted Patent US 11,634,745
Granted Patent B2
US 11,634,745 · App. 15/839,550 · Granted Apr 25, 2023

Systems and methods for sample preparation for enzymatic A1C detection and quantification

Inventors: Gary Hughes (Camby, IN); Brittney Werner (Fairland, IN)
Assignee: Polymer Technology Systems, Inc.
C12Q1/37C12Q1/004C12Q1/005G01N1/28G01N33/558G01N33/723G01N2333/90677G01N2333/96486
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,634,745
App. No.
15/839,550
Granted
Apr 25, 2023
Kind
B2
Abstract

A system for preparing a sample containing hemoglobin HbA1c for measurement by an electrochemical sensor includes a lysing formulary, the lysing formulary including a zwitterionic surfactant. The system further includes a oxidizing formulary, the oxidizing formulary including a cationic surfactant and a isothiazoline derivative and a protease formulary, the protease formulary including a molecule including an azole.

Claims (9)

1. A system for preparing a sample containing hemoglobin HbA1c for measurement by an electrochemical sensor, the system comprising:

a lysing mixture, the lysing mixture including a zwitterionic surfactant;

an oxidizing mixture, the oxidizing mixture including a cationic surfactant and an isothiazoline derivative; and

a protease mixture, the protease mixture including a molecule including an azole, wherein the system includes a sampler/mixer device, and the lysing mixture is located in the sampler/mixer device, wherein the sampler/mixer device is configured to dose a sample area of a test strip, wherein the zwitterionic surfactant is n-Tetradecyl-N,N-dimethyl-3-ammonio-1-propanesulfonate (Zwittergent 3-14®) and the cationic surfactant is 1-Dodecyl pyridinium chloride and the isothiazoline derivative is 1,2 Benzisothiazol-3(2H)-one and at a 1:5 dilution.

2. The system of claim 1 , wherein the protease mixture includes Neutral Proteinase.

3. The system of claim 2 , wherein the azole is imidazole.

4. The system of claim 3 , wherein the imidazole is in a range of 0.5 M to 2 M and at a pH of 6-8.

5. The system of claim 4 , wherein the system includes a test strip and the oxidizing mixture and protease mixture are located in the test strip.

6. The system of claim 1 , wherein the sampler/mixer device is separate from the test strip.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 16, 2018
From: HUGHES, GARY; WERNER, BRITTNEY
To: POLYMER TECHNOLOGY SYSTEMS, INC.
Reel/Frame 045821/0305 →
Continuity (2)
Provisional Application 62466983 · Mar 3, 2017
Related Publication 20180251811A1 · Sep 6, 2018